Sumatriptan Spray
Product Images NDC 0527-1859

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 0527-1859). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Suumatriptan-molec-struc (Sumatriptan Nasal Spray Usp 1)

Chemical structure of Sumatriptan, the active ingredient in the product. The diagram shows the molecular structure with labeled functional groups visible in the image.*

FDA Label Image

5mg-cl-front (Sumatriptan Nasal Spray Usp 10)

Label for Sumatriptan Nasal Spray USP 5 mg, a human prescription drug in nasal spray dosage form. The label highlights the 5 mg strength and includes the NDC number 68187-1818-43. The labeler is Lannett Company, Inc. The design includes bars and text indicating the product name and strength.*

FDA Label Image

5mg-cl-back (Sumatriptan Nasal Spray Usp 11)

Label for Sumatriptan nasal spray manufactured for Lannett Company, Inc. The label includes a barcode, manufacturing information, and a revision date of November 2020. The strength is not visible in the image.*

FDA Label Image

5mg-blister (Sumatriptan Nasal Spray Usp 12)

Label of Sumatriptan Nasal Spray USP 5 mg by Lannett Company, Inc. for intranasal use. The label lists dose strength, inactive ingredients, usage instructions, storage conditions, and manufacturing information. It includes an NDC number and barcode, with peel-off tabs on the top corners.*

FDA Label Image

5mg-carton (Sumatriptan Nasal Spray Usp 13)

Packaging label for Sumatriptan Nasal Spray USP, 5 mg strength, in a box containing 6 nasal spray units with 0.1 mL per unit. The label indicates the product is for intranasal use only and lists inactive ingredients along with storage instructions. It is labeled Rx only and manufactured for Lannett Company, Inc. The label includes a barcode and space to affix a pharmacy label.*

FDA Label Image

20mg-cl-front (Sumatriptan Nasal Spray Usp 14)

Label for Sumatriptan Nasal Spray, USP 20 mg strength by Lannett Company, Inc. The label includes barcode elements and prominently features the text indicating 'Sumatriptan Nasal Spray, USP 20 mg' along with the NDC number 63323-1859.*

FDA Label Image

20mg-cl-back (Sumatriptan Nasal Spray Usp 15)

Packaging label for Sumatriptan nasal spray by Lannett Company, Inc. It includes a curved graphic design with barcode and manufacturing information, showing lot number and expiration date fields. The label does not specify visible strength or other dosage details.*

FDA Label Image

20mg-blister (Sumatriptan Nasal Spray Usp 16)

Sumatriptan Nasal Spray, USP 20 mg label for intranasal use only. The label shows active ingredient strength, usage instructions, inactive ingredients, storage conditions, manufacturer details (Lannett Company, Inc. and Summit Biosciences Inc.), and regulatory information including NDC 0527-1859-43.*

FDA Label Image

20mg-carton (Sumatriptan Nasal Spray Usp 17)

Packaging label for Sumatriptan Nasal Spray, USP 20 mg by Lannett Company, Inc. The label indicates a nasal spray dosage form with 6 nasal spray units of 0.1 mL each, for intranasal use only. It includes inactive ingredients and storage instructions, along with the NDC 0527-1859-43 and the Lannett logo.*

FDA Label Image

Figure1 (Sumatriptan Nasal Spray Usp 2)

Line graph showing the estimated probability of response over time in minutes from initial dose for sumatriptan nasal spray at doses of 5 mg, 10 mg, and 20 mg compared to placebo. The 20 mg dose shows the highest response probability, followed by 10 mg and 5 mg, while placebo has the lowest response curve up to 120 minutes.*

FDA Label Image

Figure2 (Sumatriptan Nasal Spray Usp 3)

A line graph showing the estimated probability of remediation or rescue over time in hours from the initial dose for Sumatriptan nasal spray at doses of 5 mg, 10 mg, and 20 mg, compared to placebo. The x-axis represents time in hours, ranging from 0 to 24 hours, and the y-axis represents probability percentages from 0% to 100%. The graph displays increasing probability over time for each dose and placebo, with distinctive markers for each group.*

FDA Label Image

Figa (Sumatriptan Nasal Spray Usp 4)

Illustration showing hands peeling back foil from a Sumatriptan nasal spray single-use packaging. The package is labeled with medication information and a barcode, demonstrating how to open the unit-dose spray.*

FDA Label Image

Figb (Sumatriptan Nasal Spray Usp 5)

An instructional illustration labeled 'Figure B' showing a person holding a tissue to their nose with both hands, likely demonstrating nasal spray usage or nose care procedures.*

FDA Label Image

Figc (Sumatriptan Nasal Spray Usp 6)

Illustration labeled Figure C showing a person demonstrating the use of a nasal spray, with the spray device inserted into one nostril while the person appears to be inhaling or preparing to inhale the spray.*

FDA Label Image

Figd (Sumatriptan Nasal Spray Usp 7)

An instructional illustration showing a hand holding a Sumatriptan nasal spray device. The image labels the nozzle and plunger components, demonstrating part of the device's use or assembly process for the Sumatriptan nasal spray by Lannett Company, Inc.*

FDA Label Image

Fige (Sumatriptan Nasal Spray Usp 8)

An instructional illustration labeled Figure E showing a person demonstrating the use of Sumatriptan nasal spray. The person is holding the nasal spray device close to the nostril in preparation for administration.*

FDA Label Image

Figf (Sumatriptan Nasal Spray Usp 9)

Illustration showing a woman holding a Sumatriptan nasal spray device near her nose, demonstrating the positioning for nasal administration of the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.